Application Sponsors
ANDA 213132 | GLENMARK PHARMS LTD | |
Marketing Status
Application Products
001 | SOLUTION;INHALATION | EQ 0.015MG BASE/2ML | 0 | ARFORMOTEROL TARTRATE | ARFORMOTEROL TARTRATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-06-22 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
GLENMARK PHARMS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 213132
[companyName] => GLENMARK PHARMS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"ARFORMOTEROL TARTRATE","activeIngredients":"ARFORMOTEROL TARTRATE","strength":"EQ 0.015MG BASE\/2ML","dosageForm":"SOLUTION;INHALATION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/22\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-06-22
)
)